跳至主要内容
临床试验/CTRI/2020/06/026098
CTRI/2020/06/026098已完成未知

Efficacy and safety of intralesional Candida albicans antigen versus intralesional Mumps Measles Rubella vaccine in the treatment of multiple cutaneous warts: A double blinded Randomized Controlled Trial.

Dr JEMSHI S RAHIM0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with multiple cutaneous extragenital
  • warts (more than 3 warts) presenting to department of Dermatology
  • of AIIMS, Raipur, within the study period, who gives consent to
  • participate.

排除标准

  • 1.Pregnant and lactating ladies
  • 2.Those with uncontrolled urticaria
  • 3.Active candidiasis
  • 4.Uncontrolled asthma
  • 5.Known severe hypersensitivity to Candida albicans antigen or MMR
  • 6.Acute febrile illness
  • 7.Those receiving concomitant other treatments for warts
  • 8.Immunosuppressed patients with Human Immunodeficiency Virus (HIV)
  • infection, diabetes, post-splenectomy patients.
  • 9.Patients on immunosuppressive drugs like corticosteroids
  • 10.Past history of meningitis or convulsions
  • 11.Patients with only oral mucosal, genital, and plane warts.

研究者

发起方
Dr JEMSHI S RAHIM

相似试验